| 1976 |
Intas
Vatva unit set up by our founder - Hasmukh
Chudgar |
| 1980 |
Incorporated
and moved ahead with the concept of ethical
promotion |
| 1984 |
Started
all India marketing operations for the Neurology
and Psychiatry products |
| 1989 |
Established
Gastroenterology division with the launch of
Ciza |
| 1995 |
Set
up an ultra modern manufacturing facility at
Matoda |
| 1996 |
Secured
MHRA and TGA approvals for the Matoda facility |
| 1998 |
Forayed
into Cardiology and Diabetology with the launch
of Suprima Division |
| 2000 |
Expansion
of the Matoda factory to cater to its ever growing
needs |
| 2004 |
Intas attained the position of the fastest growing pharmaceutical company in India amongst the top
companies (Source: ORG IMS Report) |
| 2005 |
Launch
of 1st bio-pharmaceutical formulation in
Oncology "Neukine" from Gujarat |
|
"
|
Received
the award of "fastest growing mid-sized
company" by Express Pharma Pulse |
|
"
|
Grossed
Rs. 1000 Mn turnover from European operations |
|
"
|
Commenced
production of cytotoxic products at Matoda |
| 2006 |
Commenced
commercial production at the Dehradun
manufacturing facility |
|
"
|
Accomplished
backward integration process by starting API
production |
| 2007
|
Intas’ manufacturing facility at Matoda received USFDA accreditation |